Literature DB >> 9748256

The low density lipoprotein receptor active conformation of apolipoprotein E. Helix organization in n-terminal domain-phospholipid disc particles.

V Raussens1, C A Fisher, E Goormaghtigh, R O Ryan, J M Ruysschaert.   

Abstract

Lipid association is a prerequisite for receptor interactions of apolipoprotein E (apoE). Disc complexes of the N-terminal 22-kDa apoE3 receptor binding domain and dimyristoylphosphatidylcholine display full receptor binding activity. Studies have been performed to characterize conformational adaptations of the globular, lipid-free four-helix bundle structure that culminate in stable association of its amphipathic alpha-helices with a lipid surface. Helix-lipid interactions in bilayer disc complexes can conceivably adopt two orientations: parallel or perpendicular to the phospholipid acyl chains. Evidence based on infrared dichroism, geometrical arguments, and x-ray crystallography support the view that defined helical segments in the four-helix bundle realign upon lipid association, orienting perpendicular to the phospholipid fatty acyl chains, circumscribing the bilayer disc. Thus, it is likely that paired helical segments align in tandem, presenting a convex receptor-active surface.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9748256     DOI: 10.1074/jbc.273.40.25825

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Quantitation of secondary structure in ATR infrared spectroscopy.

Authors:  D Marsh
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

2.  Apolipoprotein A-V N-terminal domain lipid interaction properties in vitro explain the hypertriglyceridemic phenotype associated with natural truncation mutants.

Authors:  Kasuen Wong-Mauldin; Vincent Raussens; Trudy M Forte; Robert O Ryan
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

3.  Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents.

Authors:  Gang Zheng; Juan Chen; Hui Li; Jerry D Glickson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-23       Impact factor: 11.205

4.  Conformational flexibility in the apolipoprotein E amino-terminal domain structure determined from three new crystal forms: implications for lipid binding.

Authors:  B W Segelke; M Forstner; M Knapp; S D Trakhanov; S Parkin; Y M Newhouse; H D Bellamy; K H Weisgraber; B Rupp
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

5.  A pyrene based fluorescence approach to study conformation of apolipoprotein E3 in macrophage-generated nascent high density lipoprotein.

Authors:  Sea H Kim; Shweta Kothari; Arti B Patel; John K Bielicki; Vasanthy Narayanaswami
Journal:  Biochem Biophys Res Commun       Date:  2014-05-24       Impact factor: 3.575

Review 6.  High density lipoprotein structure-function and role in reverse cholesterol transport.

Authors:  Sissel Lund-Katz; Michael C Phillips
Journal:  Subcell Biochem       Date:  2010

7.  Nanodisk-associated amphotericin B clears Leishmania major cutaneous infection in susceptible BALB/c mice.

Authors:  Keith G Nelson; Jeanette V Bishop; Robert O Ryan; Richard Titus
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 8.  The helix bundle: a reversible lipid binding motif.

Authors:  Vasanthy Narayanaswami; Robert S Kiss; Paul M M Weers
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2009-09-19       Impact factor: 2.320

9.  Apolipoprotein E isoform-specific binding to the low-density lipoprotein receptor.

Authors:  Taichi Yamamoto; Hyung Won Choi; Robert O Ryan
Journal:  Anal Biochem       Date:  2007-09-11       Impact factor: 3.365

10.  TIP47 functions in the biogenesis of lipid droplets.

Authors:  Anna V Bulankina; Anke Deggerich; Dirk Wenzel; Kudzai Mutenda; Julia G Wittmann; Markus G Rudolph; Koert N J Burger; Stefan Höning
Journal:  J Cell Biol       Date:  2009-05-18       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.